RM1490 (Compound 251) acts as an inhibitor of μ-opioid receptor ( MOR ) ( IC 50 ≤ 300 nM), an activator of δ-opioid receptor ( DOR ) ( EC 50 > 3000 nM), and an inhibitor of κ-opioid receptor ( KOR ) ( IC 50 ≤ 300 nM). RM1490 is applicable to the research of neuropsychiatric disorders.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Opioid Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.